人参皂苷Rg1促进移植大鼠的组织工程血管内皮化

王恬然; 聂志强; 邹灏; 霍达; 许有前; 朱楚洪

doi:10.16016/j.1000-5404.201909178

您当前的位置：

首页 >

文章列表页 >

人参皂苷Rg1促进移植大鼠的组织工程血管内皮化

基础医学 | 更新时间：2026-01-09

- 人参皂苷Rg1促进移植大鼠的组织工程血管内皮化
- Ginsenoside Rg1 promotes endothelialization of tissue-engineered blood vessels in transplanted rats
- 第三军医大学学报 2020年42卷第5期页码：444-452
- 作者机构：
  
  400038 重庆，陆军军医大学(第三军医大学)基础医学院人体解剖学教研室，组织工程国家地方联合工程实验室，血管植入物国家地方联合工程实验室，烧伤、创伤与复合伤国家重点实验室，教育部生物力学与组织工程重点实验室，重庆市生物力学与组织工程重点实验室
- 作者简介：
  
  [朱楚洪，E-mail:zhuch99@yahoo.comZHU Chuhong, E-mail: zhuch99@yahoo.com
- 基金信息：
  
  国家重点研发计划重点专项(2016YFC1101100)
- DOI：10.16016/j.1000-5404.201909178
  中图分类号： R285.5;R318.11;R329.28
- 收稿：2019-09-24，
  
  修回：2019-12-16，
  
  纸质出版：2020-03-15
- 稿件说明：
移动端阅览
王恬然, 聂志强, 邹灏, 等. 人参皂苷Rg1促进移植大鼠的组织工程血管内皮化[J]. 第三军医大学学报, 2020,42(5):444-452.

Tianran WANG, Zhiqiang NIE, Hao ZOU, et al. Ginsenoside Rg1 promotes endothelialization of tissue-engineered blood vessels in transplanted rats[J]. Journal of Third Military Medical University, 2020, 42(5): 444-452.
王恬然, 聂志强, 邹灏, 等. 人参皂苷Rg1促进移植大鼠的组织工程血管内皮化[J]. 第三军医大学学报, 2020,42(5):444-452. DOI： 10.16016/j.1000-5404.201909178.

Tianran WANG, Zhiqiang NIE, Hao ZOU, et al. Ginsenoside Rg1 promotes endothelialization of tissue-engineered blood vessels in transplanted rats[J]. Journal of Third Military Medical University, 2020, 42(5): 444-452. DOI： 10.16016/j.1000-5404.201909178.

摘要

目的

包载人参皂苷Rg1(Ginsenoside Rg1，Rg1)构建促内皮化的组织工程血管(tissue-engineered blood vessels，TEBVs)，并移植大鼠颈总动脉以观察其通畅情况和内皮化效果。

方法

CCK-8和流式细胞凋亡检测培养48 h后Rg1对内皮细胞(endothelial cells，ECs)增殖和凋亡的影响，同时确定药物适宜工作浓度；将ECs分为对照组(普通培养基)、Rg1处理组(15.63 μmol/L Rg1培养基)和联合处理组，检测各组细胞培养48 h后增殖和划痕愈合情况；构建壳聚糖包被的Rg1-(2-羟丙基)-γ-环糊精颗粒(Rg1-HGC/CS NPs，以下简称NPs)并修饰至胶原血管内腔面，进行FTIR、DLS和SEM检测；体外条件下，将ECs与脱细胞血管和构建的TEBVs共培养48 h，观察其生物相容性；动物实验分为胶原组(胶原处理的血管)、空白CS组(空白CS处理的胶原组血管)和实验组(NPs处理的胶原组血管)，将其移植至SD大鼠的左侧颈总动脉；分别于30、90 d后使用超声和Micro-CT检查血管通畅情况；使用HE、Masson和(CD31 + vWF)免疫荧光观察90 d后血管的内皮化效果。

结果

Rg1通过VEGFR2对ECs产生促进增殖和迁移的作用(

0.05)，未见明显的凋亡影响；所构建的NPs粒径约为130 nm，大小均一(PDI

0.3)，并已成功修饰至血管内腔面；共培养实验表明，所构建的TEBVs生物相容性较好，利于细胞贴附生长；移植30、90 d后的影像学检测显示，实验组较其他组通畅度良好；移植90 d后的HE、Masson切片染色显示，胶原组和空白CS组的血管发生形变，失去正常结构，且因血栓和胶原纤维增生而发生阻塞，而实验组血管外形完整且无明显阻塞；CD31和vWF免疫荧光显示，实验组血管内腔面均匀覆有ECs，内皮化效果较其他组良好。

结论

所构建的促内皮化TEBVs可促进血管的内皮化进程，维持血管移植后的远期通畅。

Abstract

Objective

To prepare the endothelialization-promoting tissue-engineered blood vessels (TEBVs) with encapsulated Ginsenoside Rg1 (Rg1) to promote endothelialization

and to evaluate its patency and endothelialization after implantation into the rat common carotid artery.

Methods

CCK-8 assay and flow cytometry were used to detect the effects of Rg1 on the proliferation and apoptosis of endothelial cells (ECs) after 48 hours' treatment

and the optimal dose of the agent was also determined. ECs was divided into control group

Rg1 treatment group (15.63 μmol/L Rg1)

and Rg1+XL184 (15.63 μmol/L Rg1+0.5 μg/mL XL184

VEGFR2 inhibitor) treatment group. Cell proliferation and wound healing of ECs were examined after the treatment for 48 h. Chitosan coated Rg1-(2-hydroxypropyl)-cyclodextrin particles (Rg1-HGC/CS NPs

abbreviated as NPs) were prepared and modified to the lumen of blood vessels (after decellularization and collagen treatment)

and then Fourier transform infrared (FTIR) spectroscopy

dynamic light scattering (DLS) and scanning electron microscopy (SEM) were used to detect these obtained samples. ECs were co-cultured with acellular vessels and TEBVs for 48 h to observe the biocompatibility. For

in vivo

study

the acellular vessels were divided into collagen group (collagen treatment)

blank CS group (collagen and chitosan treatment)

and NPs group (modified with NPs). Then these vessel samples were transplanted into the left common carotid artery of SD rats respectively. Ultrasound and micro-CT scanning were performed to observe the vascular patency in 30 and 90 d after transplantation. HE and Masson staining and immunofluorescence assay for CD31 and vWF were used to observe the endothelialization in each group in 90 d after transplantation.

Results

Rg1 promoted the proliferation and migration of ECs

via

VEGFR2 (

0.05)

and showed no significant effect on apoptosis. The prepared NPs were about 130 nm in diameter and uniform in shape (PDI

0.3)

and could be successfully modified to the lumen of blood vessels. The co-cultured study showed that endothelialization-promoting TEBVs displayed better biocompatibility for favorable of cell adhesion and growth. In 30 and 90 d after transplantation

radiological studies displayed that the NPs-treated vessels showed better vascular patency than the other groups. HE and Masson staining indicated that in 90 d after transplantation

the collagen and blank CS groups had blood vessels deformed

without normal structures and blocked due to the thrombosis and collagen fibrosis

while the NPs group had intact blood vessels and better patency. Immunofluorescence assay for CD31 and vWF showed that the lumen in the vessles from the NPs group had ECs well-covered

suggesting better endothelialization when compared with other groups.

Conclusion

Endothelialization-promoting TEBVs shows better promoting effect on endothelialization

and is helpful in maintenance of long-term patency of blood vessels after transplantation.

关键词

Keywords

references

DAHL S L, KYPSON A P, LAWSON J H, et al . Readily available tissue-engineered vascular grafts[J ] . Sci Transl Med, 2011, 3(68): 68ra9. DOI:10.1126/scitranslmed.3001426.

GAUDINO M, ANTONIADES C, BENEDETTO U, et al . Mechanisms, consequences, and prevention of coronary graft failure[J ] . Circulation, 2017, 136(18): 1749-1764. DOI:10.1161/CIRCULATIONAHA.117.027597.

RATCLIFFE A. Tissue engineering of vascular grafts[J]. Matrix Biol, 2000, 19(4): 353-357. DOI:10.1016/s0945-053x(00)00080-9.

MEDZHITOV R. Inflammation 2010: new adventures of an old flame[J]. Cell, 2010, 140(6): 771-776. DOI:10.1016/j.cell.2010.03.006.

SEIFU D G, PURNAMA A, MEQUANINT K, et al . Small-diameter vascular tissue engineering[J ] . Nat Rev Cardiol, 2013, 10(7): 410-421. DOI:10.1038/nrcardio.2013.77.

SONG H G, RUMMA R T, OZAKI C K, et al . Vascular tissue engineering: progress, challenges, and clinical promise[J ] . Cell Stem Cell, 2018, 22(3): 340-354. DOI:10.1016/j.stem.2018.02.009.

VAN HINSBERGH V W. Endothelium: role in regulation of coagulation and inflammation[J]. Semin Immunopathol, 2012, 34(1): 93-106. DOI: 10.1007/s00281-011-0285-5.

SERBO J V, GERECHT S. Vascular tissue engineering: biodegradable scaffold platforms to promote angiogenesis[J]. Stem Cell Res Ther, 2013, 4(1): 8. DOI:10.1186/scrt156.

MELCHIORRI A J, HIBINO N, FISHER J P. Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts[J ] . Tissue Eng Part B Rev, 2013, 19(4): 292-307. DOI:10.1089/ten.TEB.2012.0577.

WU X D, GUO T, LIU L, et al . MiR-23a targets RUNX2 and suppresses ginsenoside Rg1-induced angiogenesis in endothelial cells[J ] . Oncotarget, 2017, 8(35): 58072-58085. DOI:10.18632/oncotarget.19489.

SENGUPTA S, TOH S A, SELLERS L A, et al . Modulating angiogenesis: the Yin and the Yang in ginseng[J ] . Circulation, 2004, 110(10): 1219-1225. DOI: 10.1161/01.CIR.0000140676.88412.CF.

LEUNG K W, NG H M, TANG M K, et al . Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis[J ] . Angiogenesis, 2011, 14(4): 515-522. DOI:10.1007/s10456-011-9235-z.

YANCOPOULOS G D, DAVIS S, GALE N W, et al . Vascular-specific growth factors and blood vessel formation[J ] . Nature, 2000, 407(6801): 242-248. DOI:10.1038/35025215.

VEIKKOLA T, ALITALO K. VEGFs, receptors and angiogenesis[J]. Semin Cancer Biol, 1999, 9(3): 211-220. DOI:10.1006/scbi.1998.0091.

YANG J Y, WEI K Y, WANG Y Q, et al . Construction of a small-caliber tissue-engineered blood vessel using icariin-loaded β-cyclodextrin sulfate for in situ anticoagulation and endothelialization[J ] . Sci China Life Sci, 2018, 61(10): 1178-1188. DOI:10.1007/s11427-018-9348-9..

REKHARSKY M V, INOUE Y.Complexation thermodynamics of cyclodextrins[J]. Chem Rev, 1998, 98(5): 1875-1918. DOI:10.1021/cr970015o.

SZEJTLI J. Medicinal applications of cyclodextrins[J]. Med Res Rev, 1994, 14(3): 353-386. DOI:10.1002/med.2610140304.

UEKAMA K. Design and evaluation of cyclodextrin-based drug formulation[J]. Chem Pharm Bull, 2004, 52(8): 900-915. DOI:10.1248/cpb.52.900.

UEKAMA K, HIRAYAMA F, IRIE T. Cyclodextrin drug carrier systems[J]. Chem Rev, 1998, 98(5): 2045-2076. DOI:10.1021/cr970025p.

CHAN R Y, CHEN W F, DONG A, et al . Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng[J ] . J Clin Endocrinol Metab, 2002, 87(8): 3691-3695. DOI:10.1210/jcem.87.8.8717.

LU X Z, WANG J H, WU X, et al . Ginsenoside Rg1 promotes bone marrow stromal cells proliferation via the activation of the estrogen receptor-mediated signaling pathway[J ] . Acta Pharmacol Sin, 2008, 29(10): 1209-1214. DOI:10.1111/j.1745-7254.2008.00874.x..

BUTTAFOCO L, ENGBERS-BUIJTENHUIJS P, POOT A A, et al . Physical characterization of vascular grafts cultured in a bioreactor[J ] . Biomaterials, 2006, 27(11): 2380-2389. DOI:10.1016/j.biomaterials.2005.10.017.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

血管周围微环境中内皮细胞通过CXCL12/CXCR4信号通路促进骨肉瘤细胞干性表型

miR-23b-3p调控脂蛋白(a)抑制同型半胱氨酸诱导的冠状动脉血管内皮细胞损伤

MiR-223通过靶向PARP1对氧化应激状态下人主动脉内皮细胞HAECs存活的影响

microRNA-145通过靶向抑制CREB调节内皮细胞增殖和血管新生

三七三醇皂苷主要成分抑制剪切力诱导的血小板活化和聚集